Skip to main content

Zoledronate, fractures, and mortality after hip fracture [4]

Publication ,  Journal Article
Colon-Emeric, CS; Lyles, KW; Mesenbrink, P
Published in: New England Journal of Medicine
February 28, 2008

Duke Scholars

Published In

New England Journal of Medicine

EISSN

1533-4406

ISSN

0028-4793

Publication Date

February 28, 2008

Volume

358

Issue

9

Start / End Page

968 / 969

Related Subject Headings

  • General & Internal Medicine
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Colon-Emeric, C. S., Lyles, K. W., & Mesenbrink, P. (2008). Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine, 358(9), 968–969.
Colon-Emeric, C. S., K. W. Lyles, and P. Mesenbrink. “Zoledronate, fractures, and mortality after hip fracture [4].” New England Journal of Medicine 358, no. 9 (February 28, 2008): 968–69.
Colon-Emeric CS, Lyles KW, Mesenbrink P. Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine. 2008 Feb 28;358(9):968–9.
Colon-Emeric, C. S., et al. “Zoledronate, fractures, and mortality after hip fracture [4].” New England Journal of Medicine, vol. 358, no. 9, Feb. 2008, pp. 968–69.
Colon-Emeric CS, Lyles KW, Mesenbrink P. Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine. 2008 Feb 28;358(9):968–969.

Published In

New England Journal of Medicine

EISSN

1533-4406

ISSN

0028-4793

Publication Date

February 28, 2008

Volume

358

Issue

9

Start / End Page

968 / 969

Related Subject Headings

  • General & Internal Medicine
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences